Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated CommLoan has streamlined the process of obtaining commercial real estate financing WARRINGTON, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company. CommLoan will retain key employees and become a subsidiary of Windtree. Windtree has provided bridge financing to CommLoan during this transition period. “Windtree is pleased to add a revenue generating fintech...

Founder Tristan Schukraft continues his mission to preserve iconic queer destinations while evolving them for a new era of gay luxury and hospitalityPool Party at The Crown & AnchorLocated in the heart of Provincetown’s historic center, The Crown & Anchor features six bars, a restaurant, a 17-room hotel, and multiple nightlife and performance venues, including The Paramount, The Crown Cabaret, and The Vault.The Crown & Anchor on Commercial Street in ProvincetownTristan Schukraft’s Tryst Hospitality announced its acquisition of The Crown & Anchor, Provincetown’s legendary hotel, restaurant, and entertainment complex on Commercial StreetProvincetown, MA, Dec. 03, 2025 (GLOBE NEWSWIRE) — Tristan Schukraft’s Tryst Hospitality announced its acquisition of The Crown & Anchor, Provincetown’s...

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued and outstanding shares, tendered prior to the expiration of the initial offering period The subsequent offering period has commenced and will expire at 12:01 a.m. Eastern Time on Thursday, December 18, 2025 MAINZ, Germany, December 3, 2025 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that 184,071,410 shares of CureVac N.V. (Nasdaq: CVAC, “CureVac”), representing approximately 81.74% of CureVac’s issued and outstanding shares, were validly tendered and not properly withdrawn prior to the expiration of the initial offering period at 9:00 a.m. Eastern Time on December 3, 2025. As a result, the minimum condition for the exchange offer (the “Offer”) has been satisfied, and all validly...

Eliminating Charging Anxiety: The combined entity will focus on commercializing StoreDot’s XFC batteries to solve the #1 consumer pain point in the electric vehicle space: long charging times. The combined entity intends to eliminate range and charging anxiety, leveraging StoreDot’s proven Extreme Fast Charging – XFC – technology.  Significant Market Opportunity: The combined entity targets the rapidly expanding EV battery market. StoreDot believes that it is positioned to capture significant market share by addressing the primary barrier to EV adoption: charging speed.  Scalable, Asset-Light Business Model: StoreDot employs a capital-efficient licensing model designed to be a “drop-in” solution compatible with existing Lithium-ion production lines. This accelerates the path to mass-market adoption...

Tongon-Mine-Côte d’IvoireTongon-Mine-Côte d’IvoireABU DHABI, United Arab Emirates, Dec. 03, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent industries, announces the completion of a US$150 million acquisition financing package to Atlantic Group to support the buyout of Tongon gold mine in Côte d’Ivoire from Barrick Mining Corporation (“Barrick Mining”). HighlightsAppian is providing US$150 million to support Atlantic Group’s buyout of Tongon mine from Barrick Mining Tongon is a gold-producing mine located in Côte d’Ivoire with significant upside potential The deal marks Appian’s fourth credit investment in the gold sector in 2025, further strengthening Appian’s exposure...

RESEARCH TRIANGLE PARK, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), with respect to BioCryst’s proposed acquisition of Astria Therapeutics, Inc. (the “Merger”). Termination of the waiting period under the HSR Act satisfied one of the conditions for consummation of the Merger. BioCryst expects the Merger to close in the first quarter of 2026, subject to other customary closing conditions. About BioCryst PharmaceuticalsBioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

The addition of the leading accessibility technology for communication design expands Quadient’s capabilities for accessible, compliant, and inclusive customer communications Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, today announced the signing of an agreement to acquire CDP Communications, a long-standing Quadient partner and one of the most innovative companies in document accessibility and automation. This acquisition reinforces Quadient’s commitment to inclusion and accessibility in customer communications and marks a significant step toward achieving the company’s Elevate to 2030 strategic objectives. More recently, compliance drivers around accessibility, in Europe and North America in particular, are requiring companies to make all digital content – including...

Acquisition highlights ETİ Gıda’s global expansion strategy and positions TRUBAR for accelerated growth in the better-for-you snacks category.TRUBAR: the plant-based protein bars VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — According to CPG Insider, TRUBAR, a better-for-you bar brand under Simply Better Brands (TSE: TRBR), was announced last week to be acquired by ETİ Gıda in a $201 million (CAD) all-cash transaction. The deal, representing a 64% premium over TRUBAR’s previous closing share price, is expected to accelerate the brand’s growth across North America while expanding its global presence. The acquisition has reportedly been recommended by TRUBAR’s Board of Directors and Special Committee, which deemed the partnership in the company’s best interest. ETİ Gıda’s experience in scaling international consumer...